Research Article

Extemporaneous Compounding and Physiological Modeling of Amlodipine/Valsartan Suspension

Table 2

Simulation input data.

ParameterValue
Amlodipine (as besylate)Valsartan

Molecular weight (g/mole)567.051435.53
Partition/distribution coefficient2.66 (pH = 7.4)a−0.34 (pH = 7)b
Pka18.7c3.9d
Pka24.73d
Solubility (mg/ml)0.774 (pH 7.4)e16.8 (pH = 8)f
Peff (human jejunal permeability) (cm/sec)0.0743 ∗ 10−4g (caco-2)0.262 ∗ 10−4h (rat)
Dose (mg)580
Dose volume (ml)250250
Mean precipitation time (sec)900i900i
Diffusion coefficient (cm2/s)4.2 ∗ 10−8j1.1 ∗ 10−8k
Drug particle density (g/ml)1.2i1.2i
Blood plasma concentration ratio1i1i
Body weight (kg)7070
Unbound percent in plasma (%)2l5m
Clearance (l/hr)28nfn
Volume of distribution, Vc (L/Kg)17n0.23n
Elimination half-life (h)27.03o5.58o
Simulation time (hr)14472

aFrom [17, 18], bfrom [19], cfrom [20, 21], d,ffrom[22], efrom [23], g from[18], hfrom [24], ifrom GastroPlus default values, j, kfrom[25], lfrom [26], mfrom [27], nGastroPlus calculated using PBPKPlus™ module, and oGastroPlus calculated (built-in calculation from PK parameters).